Ongoing and future clinical trials may clarify the role (if any) in activating AMPK in human sepsis while future research focused on tissue-specific and condition-specific AMPK activators will hopefully clarify mechanisms underlying potential efficacy. Here, PRKAA1 is linked to Sepsis.